MedKoo Cat#: 413482 | Name: Zorubicin HCl
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Zorubicin HCl is an anthracycline antineoplastic agent that targets topoisomerase II, disrupting DNA replication and transcription by stabilizing the cleavage complex and inducing double-strand breaks. It also generates reactive oxygen species (ROS), causing oxidative DNA damage and triggering apoptosis. This compound has been explored for treating solid tumors and hematologic malignancies, though its clinical use remains limited compared to other anthracyclines.

Chemical Structure

Zorubicin HCl
Zorubicin HCl
CAS#36508-71-1 (HCl)

Theoretical Analysis

MedKoo Cat#: 413482

Name: Zorubicin HCl

CAS#: 36508-71-1 (HCl)

Chemical Formula: C34H36ClN3O10

Exact Mass: 0.0000

Molecular Weight: 682.12

Elemental Analysis: C, 59.87; H, 5.32; Cl, 5.20; N, 6.16; O, 23.45

Price and Availability

Size Price Availability Quantity
10mg USD 280.00 2 Weeks
20mg USD 465.00 2 Weeks
50mg USD 835.00 2 Weeks
100mg USD 1,365.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Zorubicin HCl; NSC164011; NSC-164011; NSC 164011; Zorubicin Hydrochloride;
IUPAC/Chemical Name
N'-((E)-1-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethylidene)benzohydrazide hydrochloride
InChi Key
NKFHKYQGZDAKMX-PPRKPIOESA-N
InChi Code
InChI=1S/C34H35N3O10.ClH/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41;/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43);1H/b36-16+;/t15-,20-,22-,23-,28+,34-;/m0./s1
SMILES Code
COc1c2c(C(c3c(C2=O)c(O)c4c(C[C@](C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)(/C(C)=N/NC(c6ccccc6)=O)O)c3O)=O)ccc1.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
to be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Solvent mg/mL mM
Solubility
To be determined 0.0 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 682.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Deng S, Cui CX, Duan L, Hu L, Yang X, Wang JC, Qu LB, Zhang Y. Anticancer Drug Release System Based on Hollow Silica Nanocarriers Triggered by Tumor Cellular Microenvironments. ACS Omega. 2020 Dec 29;6(1):553-558. doi: 10.1021/acsomega.0c05032. PMID: 33458507; PMCID: PMC7807753. 2: Poochikian GK, Cradock JC, Flora KP. Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm. 1981 Apr;38(4):483-6. PMID: 6945043. 3: Jaiyesimi IA, Kantarjian HM, Estey EH. Advances in therapy for hairy cell leukemia. A review. Cancer. 1993 Jul 1;72(1):5-16. doi: 10.1002/1097-0142(19930701)72:1<5::aid-cncr2820720104>3.0.co;2-y. PMID: 7685243. 4: Alberts DS, Van Daalen Wetters T. Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system. Br J Cancer. 1976 Jul;34(1):64-8. doi: 10.1038/bjc.1976.123. PMID: 952715; PMCID: PMC2025119.